Axsome Therapeutics, Inc. (AXSM) bonds
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$187.96M
$70.00M due within a year
Net debt
-$131.89M
After $319.85M of cash
Implied interest rate
-8.65%
FY2025 interest ÷ average debt
Interest coverage
10.5×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2019
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Axsome Therapeutics's 10-Q for the period ended Jun 30, 2026
Axsome Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Revolving Facilities | $90.00M |
| Tranche One | $95.00M |
| Tranche One Sub Tranche Five | $35.00M |
| Tranche One Sub Tranche Four | $35.00M |
| Tranche One Sub Tranche One | $95.00M |
| Tranche One Sub Tranche Three | $30.00M |
| Tranche One Sub Tranche Two | $55.00M |
| Tranche Three Sub Tranche One | $15.00M |
| Tranche Three Sub Tranche Two | $5.00M |
| Tranche Three Sub Tranches to One Tranche | $75.00M |
| Tranche Two Sub Tranche One | $35.00M |
| Tranche Two Sub Tranche Three | $30.00M |
| Tranche Two Sub Tranche Two | $35.00M |
| Tranche Two Sub Tranches To One Tranche | $25.00M |
See a number that looks wrong?